Karyopharm Therapeutics (KPTI) – Rumors
-
Karyopharm Therapeutics (KPTI) CEO Cancels Leerink Conf On Scheduling Difficulties - Bloomberg
-
UPDATE: Karyopharm Therapeutics (KPTI) shares gain 13% in early trading, bucking market weakness
-
-
-
Back to KPTI Stock Lookup